title: Objective assessment of vocal hyperfunction: an experimental framework and initial results.
abstract: This report describes the experimental design and initial results of an ongoing clinical investigation of voice disorders. Its major focus is the development and use of quantitative measures to provide objective descriptions of conditions referred to as "vocal hyperfunction." The experimental design for this project is based on a descriptive theoretical framework, which holds that there are different types and stages of hyperfunctionally related voice disorders. Data consist of indirect measures derived from noninvasive aerodynamic and acoustic recordings including (a) parameters derived from inverse filtered approximations of the glottal air flow waveform; (b) estimates of transglottal pressure, average glottal air flow, glottal resistance and vocal efficiency; and (c) measures of vocal intensity and fundamental frequency. Initial results (based on comparisons among 15 voice patients and 45 normal speakers) support major assumptions that underlie the theoretical framework, and indicate that the measurement approach being utilized is capable of differentiating hyperfunctional from normal voices and hyperfunctional conditions from one another. Organic manifestations of vocal hyperfunction (nodules, polyps, contact ulcers) are accompanied by abnormally high values for the glottal waveform parameters of AC flow and maximum flow declination rate, suggesting increased potential for vocal fold trauma due to high vocal fold closure velocities and collision forces. In contrast, nonorganic manifestations of hyperfunction (functional disorders) tend to be associated with abnormally high levels of unmodulated DC flow, without high values for AC flow and maximum flow declination rate, suggesting reduced potential for vocal fold trauma. Measures also suggest different underlying mechanisms for nodules and polyps as compared to contact ulcers. Results are discussed relative to predictions based on the theoretical framework for vocal hyperfunction.
authors.affiliation: Boston University.
authors.forename: R E
authors.initials: RE
authors.lastname: Hillman
authors.forename: E B
authors.initials: EB
authors.lastname: Holmberg
authors.forename: J S
authors.initials: JS
authors.lastname: Perkell
authors.forename: M
authors.initials: M
authors.lastname: Walsh
authors.forename: C
authors.initials: C
authors.lastname: Vaughan
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007818:Laryngeal Diseases / Q000150:complications / Q000209:etiology / Q000503:physiopathology; D007822:Laryngeal Neoplasms / Q000150:complications / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011127:Polyps / Q000150:complications / Q000209:etiology / Q000503:physiopathology; D014456:Ulcer / Q000150:complications / Q000209:etiology / Q000503:physiopathology; D014827:Vocal Cords / Q000293:injuries / Q000503:physiopathology; D014832:Voice Disorders / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology